Immune cell profiles and clinical and safety outcomes with fingolimod in the 12 month FLUENT study

Presentation information

English Poster Session

Wed. May 19, 2021 6:15 PM - 6:55 PM Room 15 (ICC Kyoto 1F New Hall)

^○Kengo Ueda (Neuroscience Medical Franchise Dept. Medical Division, Novartis Pharma K.K., Japan)

Abstract password authentication.
Password is written on a pocket program and name badge.